Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

A series of antibacterial compounds described in patent literature

Jan. 14, 2005

Pfizer researchers report discovery of compounds with utility in diagnosis of CNS disorders

Jan. 14, 2005

Scientists at 3-Dimensional Pharmaceuticals present novel protein tyrosine kinase inhibitors

Jan. 14, 2005

A series of quinolones for the treatment of CNS disorders

Jan. 14, 2005

sanofi-aventis patent claims CCR2B receptor antagonists

Jan. 14, 2005

PDE4 inhibitors described by Merck Frosst

Jan. 14, 2005

Antiinfective agents claimed by GlaxoSmithKline

Jan. 13, 2005

Roche scientists prepare and test new agents for cancer

Jan. 13, 2005

GSK team identifies new 5-HT5A receptor ligands for CNS disorders

Jan. 13, 2005

HIV integrase inhibitors in early development at Bristol-Myers Squibb

Jan. 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...